SERTAD1 c.226C>T ;(p.R76C)

Variant ID: 19-40929228-G-A

NM_013376.3(SERTAD1):c.226C>T;(p.R76C)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


mTOR Signaling and SREBP Activity Increase FADS2 Expression and Can Activate Sapienate Biosynthesis.

Cell Reports
Triki, Mouna M; Rinaldi, Gianmarco G; Planque, Melanie M; Broekaert, Dorien D; Winkelkotte, Alina M AM; Maier, Carina R CR; Janaki Raman, Sudha S; Vandekeere, Anke A; Van Elsen, Joke J; Orth, Martin F MF; Grünewald, Thomas G P TGP; Schulze, Almut A; Fendt, Sarah-Maria SM
Publication Date: 2020-06-23

Variant appearance in text: SERTAD1: R76C
PubMed Link: 32579932
Variant Present in the following documents:
  • mmc5.xlsx, sheet 3
View BVdb publication page



Prognostic and Clinicopathological Significance of SERTAD1 in Various Types of Cancer Risk: A Systematic Review and Retrospective Analysis.

Cancers
Mongre, Raj Kumar RK; Jung, Samil S; Mishra, Chandra Bhushan CB; Lee, Beom Suk BS; Kumari, Shikha S; Lee, Myeong-Sok MS
Publication Date: 2019-03-08

Variant appearance in text: SERTAD1: R76C
PubMed Link: 30857225
Variant Present in the following documents:
  • cancers-11-00337-s001.pdf
View BVdb publication page